Periodontal Care and Glycemic Control in Diabetes
Information source: Department of Veterans Affairs
Information obtained from ClinicalTrials.gov on June 20, 2008
Link to the current ClinicalTrials.gov record.
Condition(s) targeted: Diabetes Mellitus; Poor Glycemic Control; Peridontal Disease
Intervention: Doxycycline HCI 10mg po for 2 weeks (Drug); Ultrasonic scaling with 0.12% chlorhexidine gluconate (Procedure)
Phase: N/A
Status: Completed
Sponsored by: Department of Veterans Affairs Official(s) and/or principal investigator(s):
Judith A. Jones, DDS MPH DSc, Principal Investigator, Affiliation: VA New England Health Care System
Summary
Diabetes is a prevalent and costly disease among users of VA care. Goals of diabetes care
include the prevention and/or delay of complications via adequate glycemic control.
Improvements in periodontal status may also improve diabetes control.
Clinical Details
Official title: Periodontal Care and Glycemic Control in Diabetes
Study design: Treatment, Randomized, Single Blind, Active Control, Factorial Assignment, Efficacy Study
Eligibility
Minimum age: N/A.
Maximum age: N/A.
Gender(s): Both.
Criteria:
Inclusion Criteria:
Patients must have diabetes mellitus, and HbAlc >9, >8 teeth, and CPITN scores of 3 or 4
in, at least 2 sextants of the mouth, indicating moderate to high peridontal treatment
need.
Exclusion Criteria:
Locations and Contacts
VA New England Health Care System, Bedford, Massachusetts 01730, United States
VA Medical Center, Jamaica Plain Campus, Boston, Massachusetts 02130, United States
Additional Information
Last updated: April 23, 2008
|
